BRUKER CORPORATION Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax
BRUKER CORPORATION (BRKR) reported Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax of -$22.50 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax · last filed 2026-08-05
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2026-06-30 was -$22.50M, a 116.88% decline year-over-year.
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2026-03-31 was -$28.90M, a 140.53% decline year-over-year.
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2025-12-31 was -$8.20M.
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for the quarter ending 2025-09-30 was $33.60M, a 51.59% decline year-over-year.
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2025 was $230.00M.
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2024 was -$160.00M, a 265.80% decline from fiscal 2023.
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2023 was $96.50M.
- BRUKER CORPORATION other comprehensive income (loss), foreign currency transaction and translation adjustment, before tax for fiscal 2022 was -$66.00M.
| Period end | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 3 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 6 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 9 month | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$22.50M 10-Q · filed 2026-08-05 | -$51.40M 10-Q · filed 2026-08-05 | -$59.60M derived: sum of 3 quarters · filed 2026-08-05 | -$26.00M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | -$28.90M 10-Q · filed 2026-05-07 | -$37.10M derived: sum of 2 quarters · filed 2026-05-07 | -$3.50M derived: sum of 3 quarters · filed 2026-05-07 | $129.80M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | -$8.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $25.40M derived: sum of 2 quarters · filed 2026-02-27 | $158.70M derived: sum of 3 quarters · filed 2026-08-05 | $230.00M 10-K · filed 2026-02-27 |
| 2025-09-30 | $33.60M 10-Q · filed 2025-11-05 | $166.90M derived: sum of 2 quarters · filed 2026-08-05 | $238.20M 10-Q · filed 2025-11-05 | $117.30M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $133.30M 10-Q · filed 2026-08-05 | $204.60M 10-Q · filed 2026-08-05 | $83.70M derived: sum of 3 quarters · filed 2026-08-05 | $153.10M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $71.30M 10-Q · filed 2026-05-07 | -$49.60M derived: sum of 2 quarters · filed 2026-05-07 | $19.80M derived: sum of 3 quarters · filed 2026-05-07 | -$9.10M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$120.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$51.50M derived: sum of 2 quarters · filed 2026-02-27 | -$80.40M derived: sum of 3 quarters · filed 2026-02-27 | -$160.00M 10-K · filed 2026-02-27 |
| 2024-09-30 | $69.40M 10-Q · filed 2025-11-05 | $40.50M derived: sum of 2 quarters · filed 2025-11-05 | -$39.10M 10-Q · filed 2025-11-05 | |
| 2024-06-30 | -$28.90M 10-Q · filed 2025-08-06 | -$108.30M 10-Q · filed 2025-08-06 | ||
| 2024-03-31 | -$79.40M 10-Q · filed 2025-05-07 | |||
| 2023-12-31 | $96.50M 10-K · filed 2026-02-27 | |||
| 2022-12-31 | -$66.00M 10-K · filed 2025-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |